drugset / Trial / NCT04168112

Intracanalicular Dexamethasone Insert for Post-Corneal Cross-Linking Inflammation and Pain- The LINK Study

NCT04168112 ↗

RandomizedParallel-groupOpen-labelSupportive care

Summary

There is no standard of care medication regimen for the management of pain and inflammation post-corneal crosslinking (CXL), although most cornea specialists agree on use of an antibiotic and steroid eye drop in the immediate postoperative period. However, steroid tapering schedule and use of additional topical non-steroidal anti-inflammatory (NSAID) eyedrops vary amongst practitioners. The goal of this study is to compare postoperative pain scores between patients receiving a tapering dose of topical steroids over 1-month post-CXL, versus those receiving an intracanalicular dexamethasone insert.

Timeline

Start
2020-02-12
Primary completion
2022-10-24
Completion
2023-04-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule — Other
Comparator Prednisolone Other / unclassified 1 % Topical

Indications